Skip to main content
OpenTrials
Completed

NCT Number: NCT03928587

Effect of 12 Months Supplementation With a Symbiotic Lozenge on Caries Increment in Healthy Children

The primary objective of this trial is to investigate the effect of a symbiotic lozenge on dental caries in young children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

5 year–8 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Copenhagen

Copenhagen, Denmark

About this study

The study is a multicentre, randomized, double-blind, placebo-controlled, parallel-group study in healthy children aged 5-8 years. The objective is to investigate the effect of a symbiotic lozenge on caries increment in primary molar teeth, primary canines and erupted occlusal surfaces at the first permanent molar teeth.The study will take place in Helsingør and Fredensborg municipality.

The study consists of a baseline visit prior to a 12 months intervention period, followed by a visit after completion. During the intervention period, two to four months after the baseline visit, a saliva sample will be collected.

All guardians to the subjects are encouraged to 1) brush their children's teeth twice daily with the fluoride toothpaste provided, 2) avoid the food provided in appendix D and 3) to continue the subject's dental appointments at local Public Dental Health Service (PDHS). No further specific oral hygiene or dietary instructions/restrictions are provided.

Assuming a dropout rate of 12.5%, 175 children will be included in each treatment group.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy children with absence of severe chronic disease
  • Age 5-8 years, both inclusive, at inclusion
  • Ability to cooperate at dental examination
  • Ability to cooperate to a daily intake of a lozenge
  • Parents/legal guarding provided voluntary written informed consent

Exclusion criteria

  • Children with severe medical conditions
  • Mentally or physically disabled children
  • Children of parents with language barriers and not able to give written informed consent

Treatment and study plan

2 billion CFU in total of the two strains Lactobacillus paracasei subsp. paracasei and Lactobacillus rhamnosus and arginine.

Dietary Supplement

One lozenge once daily for 12 months

Placebo

Dietary Supplement

Placebo once daily for 12 months

Primary outcomes

  1. Increase in caries incidence

    Time frame: 12 months

    Caries increment in primary molar teeth, primary canines and erupted occlusal surfaces at the first permanent molar teeth in children aged 5-8 years, using a modified dmf-s scale, including the occlusal surfaces of the first permanent teeth where d is defined by ICDAS scale and assessed both clinically and by dental x-ray.

Sponsors and collaborators

Lead sponsor

Chr Hansen

Industry

Collaborators

  • University of Copenhagen

Registry information

Official study title

Effect of 12 Months Supplementation With a Symbiotic Lozenge on Caries Increment in Healthy Children: A Randomized, Parallel-grouped, Placebo-controlled Trial

Acronym: PiP-C

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Apr 26, 2019
Registry last updated
Oct 3, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.